ZYDUSLIFE

Zydus Lifesciences LimitedNSE
₹1,145.5-11.40 (-0.99%)

Market Closed · NSE · INR

Open

₹1,161.7

High

₹1,167.7

Low

₹1,142

Prev Close

₹1,156.9

52-Week Range83% from low
₹860.6
₹1,205

Market Cap

₹1.15 L Cr

Large Cap

P/E (TTM)

25.78

EPS

₹44.87

Div Yield

0.09%

P/B Ratio

5.17

ROE

15.5%

Key Metrics

Forward P/E23.52
Book Value₹221.57
Debt/Equity0.40×
Revenue Growth22.0%
Profit Margin16.06%
Operating Margin27.54%
Volume20.09 L
Avg Volume (20d)17.92 L
Delivery %51.36%
Trades42,160

Analyst Ratings(30 analysts)

Hold

Target Price

₹1,196

+4.4% upside

Strong Buy7
Buy8
Hold8
Sell3
Strong Sell4
Low: ₹800Median: ₹1,202High: ₹1,457

Current price: ₹1,146

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The co...

zyduslife.com29,980 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 12.00/share
23
24
25
26
24 Jul 20261.00
25 Jul 202511.00
26 Jul 20243.00
28 Jul 20236.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.